Free tool
Find any stock
Search all ~22,000 companies we cover across the US, Europe and Asia-Pacific, or browse them market by market — then open any one of them for the full analysis.
Search all ~22,000 companies we cover across the US, Europe and Asia-Pacific, or browse them market by market — then open any one of them for the full analysis.
Search all ~22,000 companies we cover across the US, Europe and Asia-Pacific, or browse them market by market — then open any one of them for the full analysis.
145 stocks in the US match these filters · market cap, largest first. Clear filters
Data as of Aug 26, 2026 · updates nightly, Mon–Sat
| Ticker | Company | Sector | Market cap (USD) | Price | vs 52-week high | 1M return |
|---|---|---|---|---|---|---|
| PODD | Insulet Corporation | Healthcare | $9.92B | $143.05 | −59.69% | −13.30% |
| NUVL | Nuvalent Inc | Healthcare | $9.79B | $123.96 | −0.02% | 0.00% |
| BIO-B | Bio-Rad Laboratories, Inc. | Healthcare | $9.77B | $365.08 | 0.00% | +18.01% |
| AVTR | Avantor, Inc. | Healthcare | $9.75B | $14.42 | −9.48% | +22.62% |
Every company we cover sits in at least one of these lists. Each one opens as a full table of its members, ordered by market value.
The 11 business sectors every covered company is classified into.
The 20 narrower groupings we keep for parts of the market that do not split neatly by sector.
Price chart, technicals, money flow, fundamentals and an AI-written read — one page per stock, $9.90 each. Already know the symbol?
| OSCR | Oscar Health, Inc. | Healthcare | $9.55B | $30.93 | −7.80% | +9.14% |
| TWST | Twist Bioscience Corporation | Healthcare | $9.50B | $151.42 | −2.28% | +74.97% |
| SYRE | Spyre Therapeutics, Inc. | Healthcare | $9.32B | $107.36 | −2.56% | +7.32% |
| PCVX | Vaxcyte, Inc. | Healthcare | $9.09B | $61.09 | −6.02% | +10.07% |
| CRNX | Crinetics Pharmaceuticals, Inc. | Healthcare | $9.00B | $84.86 | 0.00% | +1.20% |
| IMVT | Immunovant, Inc. | Healthcare | $8.95B | $43.50 | −4.23% | +8.51% |
| HQY | HealthEquity, Inc. | Healthcare | $8.83B | $105.39 | −2.08% | +6.40% |
| BRKR | Bruker Corporation | Healthcare | $8.66B | $56.85 | −12.94% | −5.33% |
| ATR | AptarGroup, Inc. | Healthcare | $8.57B | $134.72 | −8.30% | +1.37% |
| TGTX | TG Therapeutics, Inc. Common Stock | Healthcare | $8.48B | $56.01 | −5.55% | +0.47% |
| TXG | 10x Genomics, Inc. | Healthcare | $8.43B | $64.72 | −3.32% | +40.94% |
| RYTM | Rhythm Pharmaceuticals, Inc. | Healthcare | $7.78B | $113.35 | −7.24% | +6.80% |
| HIMS | Hims & Hers Health, Inc. | Healthcare | $7.41B | $31.75 | −51.38% | +4.99% |
| CAI | Caris Life Sciences, Inc. | Healthcare | $7.38B | $28.01 | −34.09% | +79.21% |
| HNGE | Hinge Health, Inc. | Healthcare | $7.25B | $89.87 | −3.50% | +19.65% |
| CHE | Chemed Corporation | Healthcare | $7.11B | $543.98 | −2.34% | +6.80% |
| SRRK | Scholar Rock Holding Corporation | Healthcare | $7.09B | $58.25 | −2.07% | +19.05% |
| PACS | PACS Group, Inc. | Healthcare | $7.00B | $43.94 | −11.21% | −6.67% |
| CGON | CG Oncology, Inc. | Healthcare | $7.00B | $78.95 | −2.49% | +7.39% |
| ORKA | Oruka Therapeutics, Inc. | Healthcare | $6.74B | $101.82 | −11.86% | +12.88% |
| E2XE34.SA | Exelixis, Inc. | Healthcare | $6.61B | 137.40 BRL | −2.25% | −2.25% |
| LNTH | Lantheus Holdings, Inc. | Healthcare | $6.58B | $100.87 | −9.82% | −6.63% |
| BLTE | Belite Bio, Inc | Healthcare | $6.51B | $161.68 | −19.16% | +2.05% |
| COGT | Cogent Biosciences, Inc. | Healthcare | $6.39B | $36.80 | −15.85% | −9.00% |
| LQDA | Liquidia Corporation | Healthcare | $6.31B | $70.49 | −24.70% | −16.50% |
| AMRX | Amneal Pharmaceuticals, Inc. | Healthcare | $6.24B | $17.92 | −6.96% | −0.94% |
| ERAS | Erasca, Inc. | Healthcare | $6.16B | $17.76 | −26.85% | −5.88% |
| PTCT | PTC Therapeutics, Inc. Common Stock | Healthcare | $6.13B | $73.47 | −19.15% | −3.07% |
| DNTH | Dianthus Therapeutics, Inc. | Healthcare | $6.13B | $112.11 | −4.89% | +7.29% |
| TVTX | Travere Therapeutics, Inc. | Healthcare | $6.06B | $67.01 | −0.49% | +18.23% |
| RDNT | RadNet, Inc. | Healthcare | $6.05B | $76.86 | −10.46% | +24.96% |
| DFTX | Definium Therapeutics, Inc. | Healthcare | $6.02B | $44.81 | −9.84% | +5.06% |
| T1FX34.SA | Teleflex Incorporated | Healthcare | $6.00B | 69.78 BRL | −6.95% | 0.00% |
| MIRM | Mirum Pharmaceuticals, Inc. | Healthcare | $5.98B | $98.08 | −24.55% | −14.12% |
| TFX | Teleflex Incorporated | Healthcare | $5.94B | $140.18 | −3.32% | +6.97% |
| LGND | Ligand Pharmaceuticals Incorporated | Healthcare | $5.62B | $281.72 | −13.75% | −5.30% |
| MMED | MiniMed Group, Inc. | Healthcare | $5.60B | $18.92 | −9.39% | +7.07% |
| SHC | Sotera Health Company | Healthcare | $5.57B | $19.51 | −1.71% | +13.17% |
| MMSI | Merit Medical Systems, Inc. | Healthcare | $5.44B | $91.09 | −3.86% | +19.70% |
| ACAD | ACADIA Pharmaceuticals Inc. | Healthcare | $5.23B | $30.57 | −1.26% | +20.40% |
| HAE | Haemonetics Corporation | Healthcare | $4.93B | $108.32 | −1.14% | +35.55% |
| DYN | Dyne Therapeutics, Inc. | Healthcare | $4.92B | $26.34 | −3.53% | +2.77% |
| EWTX | Edgewise Therapeutics, Inc. | Healthcare | $4.80B | $44.21 | −8.66% | +6.27% |
| BLLN | BillionToOne, Inc. | Healthcare | $4.72B | $100.08 | −33.48% | −21.80% |
| LFST | LifeStance Health Group, Inc. | Healthcare | $4.69B | $12.28 | −5.28% | +12.87% |
| WAY | Waystar Holding Corp. | Healthcare | $4.64B | $24.21 | −41.62% | +4.69% |
| ICUI | ICU Medical, Inc. | Healthcare | $4.56B | $182.24 | −5.50% | +12.87% |
| DOCS | Doximity, Inc. | Healthcare | $4.51B | $24.74 | −67.66% | +17.87% |
| RLAY | Relay Therapeutics, Inc. | Healthcare | $4.51B | $20.57 | −3.29% | +10.35% |
| ELVN | Enliven Therapeutics, Inc. | Healthcare | $4.48B | $61.01 | −2.10% | +15.69% |
| CELC | Celcuity Inc. | Healthcare | $4.44B | $92.27 | −38.90% | +12.16% |
| CON | Concentra Group Holdings Parent, Inc. | Healthcare | $4.44B | $34.78 | −3.12% | +9.06% |
| NVST | Envista Holdings Corporation | Healthcare | $4.39B | $27.47 | −9.70% | +3.12% |
| HTFL | Heartflow, Inc. | Healthcare | $4.34B | $49.89 | −2.54% | +96.65% |
| ITGR | Integer Holdings Corporation | Healthcare | $4.25B | $125.39 | −0.59% | +26.15% |
| INDV | Indivior Pharmaceuticals, Inc. | Healthcare | $4.24B | $35.97 | −15.98% | −10.14% |
Covers ~22,000 companies across the US, Europe and Asia-Pacific (ex mainland China, Hong Kong and India), refreshed nightly. Every listed stock opens as a full analysis for $9.90.
Size bands, from the largest companies down to the smallest we cover.
The 23 listing venues our coverage spans, across the Americas, Europe and Asia-Pacific.
5 lists built on a single stated criterion, such as paying a dividend or trading near a 52-week high.
The largest one day percentage moves in either direction, among the mid, large and mega cap companies we cover.